1093 (1093) News
Track canonical SquawkNews coverage tagged to 1093, 1093. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
CSPC Pharmaceutical’s SYS6010 gets Breakthrough Therapy designation
CSPC Pharmaceutical said SYS6010 was granted Breakthrough Therapy designation by the NMPA.
EQUITY | Sep 01, 2026, 10:31 AM UTC
L
CSPC Pharmaceutical starts Phase I trial of SYH2092 injection
CSPC Pharmaceutical has initiated a Phase I clinical trial of SYH2092 injection.
EQUITY | Aug 31, 2026, 03:29 PM UTC